Andrew Blight, Chief Scientific Officer at ACORDA THERAPEUTICS INC (ACOR), sold 5,300 shares at $32.61 ($173K) on 2008-06-05, disclosed to the SEC on 2008-06-09.
Scheduled sale ($173k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.38 | 300 | $10K | 5.6% |
| 2 | $32.39 | 400 | $13K | 7.5% |
| 3 | $32.40 | 100 | $3K | 1.9% |
| 4 | $32.41 | 100 | $3K | 1.9% |
| 5 | $32.42 | 200 | $6K | 3.8% |
| 6 | $32.43 | 200 |
| $6K |
| 3.8% |
| 7 | $32.44 | 200 | $6K | 3.8% |
| 8 | $32.45 | 300 | $10K | 5.6% |
| 9 | $32.46 | 200 | $6K | 3.8% |
| 10 | $32.47 | 100 | $3K | 1.9% |
| 11 | $32.48 | 200 | $6K | 3.8% |
| 12 | $32.51 | 200 | $7K | 3.8% |
| 13 | $32.52 | 100 | $3K | 1.9% |
| 14 | $32.55 | 100 | $3K | 1.9% |
| 15 | $32.56 | 100 | $3K | 1.9% |
| 16 | $32.59 | 100 | $3K | 1.9% |
| 17 | $32.60 | 100 | $3K | 1.9% |
| 18 | $32.61 | 300 | $10K | 5.7% |
| 19 | $32.62 | 200 | $7K | 3.8% |
| 20 | $32.65 | 300 | $10K | 5.7% |
| 21 | $32.66 | 200 | $7K | 3.8% |
| 22 | $32.67 | 100 | $3K | 1.9% |
| 23 | $32.69 | 100 | $3K | 1.9% |
| 24 | $32.71 | 300 | $10K | 5.7% |
| 25 | $32.72 | 445 | $15K | 8.4% |
| 26 | $32.73 | 255 | $8K | 4.8% |
| 27 | $32.90 | 100 | $3K | 1.9% |
| Total | $32.56 avg | 5,300 | $173K | 100% |
| Filing → |
| ACOR | SELL | 2015-11-23 | $19K | — | Filing → |
| ACOR | SELL | 2015-10-21 | $1.0M | — | Filing → |
| ACOR | SELL | 2015-09-23 | $410K | — | Filing → |